Targeted drug delivery to the brain for treating neur...
Novel drug delivery vehicles capable of directly targeting areas of the brain affected by abnormal tau aggregation, in dis...
Virtual Assay drug screening software V.3.0
Easy to use drug screening software that allows users to produce a population of models for quantitative prediction of dru...
Breakthrough technology for non-invasive prenatal tes...
A high-throughput non-invasive prenatal testing technique for the diagnosis of sickle-cell disease in the foetus.
A method for precisely tuning gene expression levels ...
Researchers at the University of Oxford have developed a method for precise, stepwise control of endogenous gene expressio...
Non-invasive PET imaging of PARP expression
The first synthesised [18F]-labelled olaparib as PARP imaging agent for clinical PET
Rotary Renewable Generation
Turning common induction motors into efficient, economic, low-maintenance, gearless electrical generators.
The therapeutic potential of chemically synthesised o...
Researchers at the University of Oxford have developed a chemical synthesis strategy for producing DNA incorporating non-n...
Speckle Reducer for laser imaging, projection display...
Oxford researchers have developed a new device for tackling the problem of “speckle” when using lasers for displays an...
Acute myeloid leukaemia prognostic and diagnostic scr...
Oxford researchers, in collaboration with the University of Birmingham, have discovered novel combinations of cell-surface...
Quantiphyse: Improved analysis of biomedical imaging ...
A tool to accurately view and analyse biomedical imaging data
Hepatitis C vaccine
A viral-vectored vaccine incorporating a novel immunogen for a pan-genotypic Hepatitis C protection based on genomic segme...
Single-molecule phenotyping coupled with in situ sing...
Oxford researchers have developed a novel single-molecule sequencing method capable of connecting the functionality of a s...
© Oxford University Innovation